Find A Doctor Find A Service Make An Appointment Talk To A Doctor

RESEARCHbanner
increase text size decrease text size printer friendly



  • Breast Cancer

  • Breast Cancer

    Title(s):
    SWOG 1207. Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients with High-Risk, Hormone Receptor-Positive and HER2/neu Negative Breast Cancer

    Investigator(s):
    Esther Rehmus, MD

    Contact Information:
    McDowell Cancer Research at 330-344-6348

  • Breast Cancer

    Title(s):
    NSABP B-51/RTOG 1304. A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chest Wall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients with Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy

    Investigator(s):
    Andrew Fenton, MD

    Contact Information:
    McDowell Cancer Research at 330-344-6348

  • Breast Cancer

    Title(s):
    CTSU E2112. A Randomized Phase III Trial of Endocrine Therapy plus Entinostat/Placebo in Postmenopausal Patients with Hormone Receptor-Positive Advanced Breast Cancer

    Investigator(s):
    Esther Rehmus, MD

    Contact Information:
    McDowell Cancer Research at 330-344-6348

  • Breast Cancer

    Title(s):
    NSABP B-55/BIG 6-13. A Randomised, Double-Blind, Parallel Group, Placebo-Controlled Multi-Centre Phase III Study to Assess the Efficacy and Safety of Olaparib Versus Placebo as Adjuvant Treatment in Patients with Germline BRCA1/2 Mutations and High Risk HER2 Negative Primary Breast Cancer Who Have Completed Definitive Local Treatment and Neoadjuvant or Adjuvant Chemotherapy

    Investigator(s):
    Andrew Fenton, MD

    Contact Information:
    McDowell Cancer Research at 330-344-6348

  • Breast Cancer

    Title(s):
    CTSU A011202. A Randomized Phase III Trial Evaluating the Role of Axillary Lymph Node Dissection in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy

    Investigator(s):
    Esther Rehmus, MD

    Contact Information:
    McDowell Cancer Research at 330-344-6348

  • Breast Cancer

    Title(s):
    CTSU EA1131. A Randomized Phase III Post-Operative Trial of Platinum Based Chemotherapy Vs. Observation in Patients with Residual Triple-Negative Basal-Like Breast Cancer following Neoadjuvant Chemotherapy

    Investigator(s):
    Esther Rehmus, MD

    Contact Information:
    McDowell Cancer Research at 330-344-6348

  • Breast Cancer

    Title(s):
    NRG-BR003. A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel with or Without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer

    Investigator(s):
    Esther Rehmus, MD

    Contact Information:
    McDowell Cancer Research at 330-344-6348

  • Breast Cancer

    Title(s):
    CTSU A011203. A Randomized Phase II Trial of Tamoxifen Versus Z-Endoxifen HCl in Postmenopausal Women with Metastatic, Estrogen Receptor Positive, HER2 Negative Breast Cancer

    Investigator(s):
    Esther Rehmus, MD

    Contact Information:
    McDowell Cancer Research at 330-344-6348

  • Breast Cancer

    Title(s):
    NRG-BR002. A Phase IIR/III Trial of Standard of Care with or without Stereotactic Body Radiotherapy (SBRT) and/or Surgical Ablation for Newly Oligometastatic Breast Cancer

    Investigator(s):
    Mitchell Fromm, MD

    Contact Information:
    McDowell Cancer Research at 330-344-6348

  • Breast Cancer

    Title(s):
    NRG-BR001. A Phase 1 Study of Stereotactic Body Radiotherapy (SBRT) for the Treatment of Multiple Metastases

    Investigator(s):
    Mitchel Fromm, MD

    Contact Information:
    McDowell Cancer Research at 330-344-6348

  • Breast Cancer

    Title(s):
    15045. Measuring the Impact of MammaPrint on Adjuvant and Neoadjuvant Treatment in Breast Cancer Patients: A Prospective Registry (IMPACt)

    Investigator(s):
    Esther Rehmus, MD

    Contact Information:
    McDowell Cancer Research at 330-344-6348

  • Breast Cancer

    Title(s):
    15043. Nipple Sparing Mastectomy Registry

    Investigator(s):
    Mary Murray, MD

    Contact Information:
    McDowell Cancer Research at 330-344-6348

  • Breast Cancer

    Title(s):
    CTSU A011104 / 6694. Effect of Preoperative Breast MRI on Surgical Outcomes, Costs and Quality of Life of Women with Breast Cancer

    Investigator(s):
    Esther Rehmus, MD

    Contact Information:

  • Breast Cancer

    Title(s):
    CTSU A221102. Randomized Double-Blind Placebo Controlled Study Of Testosterone In The Adjuvant Treatment Of Postmenopausal Women With Aromatase Inhibitor Induced Arthralgias

    Investigator(s):
    Esther Rehmus, MD

    Contact Information:
    McDowell Cancer Research at 330-344-6348

  • Breast Cancer

    Title(s):
    CTSU A011401. Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer

    Investigator(s):
    Esther Rehmus, MD

    Contact Information:
    McDowell Cancer Research at 330-344-6348

  •  




    Cleveland Clinic Akron General • 1 Akron General Avenue • Akron, OH 44307 • 330.344.6000 • 1.800.221.4601    © 2016 Cleveland Clinic Akron General



    This website is certified by Health On the Net Foundation. Click to verify.

      This site complies with the HONcode standard for trustworthy health information: verify here.